Find Federal Grants
Medicare Rural Hospital Flexibility Program – Emergency Medical Services Supplement
Health Resources and Services Administration · HRSA-24-006
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R9-0104
Ukraine USAID-Kiev · 72012124RFA00001
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
National Institutes of Health · RFA-NR-24-004
Request for Information: Supporting Successful Solar Plus Storage Deployment Serving Low-Income and Disadvantaged Communities
Golden Field Office · DE-FOA-0003304
U.S. Mission to the Republic of the Congo · PDS-BRAZZAVILLE-FY24-03
69A355 Research and Technology · STEEL-SLAG
Development and Testing Advancements in Spectral Wave Measurements, and Nearshore Process Methods for Risk-Based Guidance
Engineer Research and Development Center · W81EWF-24-SOI-0012
Mexico USAID-Mexico City · RFI-2024-003
U.S. Mission to Bosnia and Herzegovina · BH-004-FY2024
U.S. Mission to Bosnia and Herzegovina · BH-003-FY2024
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
National Institutes of Health · NOT-NR-24-005
Youth Activism Program FY2024
U.S. Mission to Albania · TIRYOUTHACTIVISMFY24
Pakistan USAID-Islamabad · 72039124RFI00002
U.S. National Science Foundation · 24-528
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
National Institutes of Health · PAR-24-129
FY 2023 and FY 2024 Rural Capacity Building for Community Development and Affordable Housing Grants (RCB)
Department of Housing and Urban Development · FR-6700-N-08
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
National Institutes of Health · PAR-24-113
Cooperative Agreement for CESU-affiliated Partner with Pacific Northwest Cooperative Ecosystem Studies Unit
Geological Survey · G24AS00235
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
National Institutes of Health · PAR-24-097